Single Slide Assessment: the future of molecular testing in lung cancer?
Conclusions: SSA is highly effective at preserving samples for molecular testing from EBUS-FNA. Therefore a single minimally invasive procedure offers access to novel immunotherapy, enhancing lung cancer care. With increasing emphasis on immunotherapy its value is likely to increase.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Diggins, B., Glinski, L., Garvican, J., Wijesinghe, M. Tags: Lung Cancer Source Type: research
Related Links:
Conclusion: This study highlights that the adenocarcinoma incidence is surpassing squamous cell carcinoma in Indian lung cancer patients also, as observed in Western population. Mean age at diagnosis is about one decade earlier than in the Western population. Driver mutations are more common in India than in the West as also reported in other Asian studies.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: HS Darling Sundaram Viswanath Rajeshwar Singh Subhas Ranjan Nikhil Pathi Anvesh Rathore Abhishek Pathak Rahul Sud Source Type: research
Conclusion Patients with lung cancer and pulmonary tuberculosis are predominantly male with smoking history. Adenocarcinoma is the most common pathological type. The positive rate of gene mutation was not significantly different from that of simple lung cancer , but when there were cavities in the chest image, the genetic mutation rate was significantly reduced. DOI: 10.3779/j.issn.1009-3419.2020.101.25
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research
Conclusion: Among this large cohort, our center seems to follow the global trend with increasing incidence of ADC. EGFR mutation positivity was similar to existing reports, while higher ALK positivity was detected. A characteristic phenotype of never-smokers with lung cancer was elucidated which demonstrated better survival.
Source: Lung India - Category: Respiratory Medicine Authors: Anant Mohan Avneet Garg Aditi Gupta Satyaranjan Sahu Chandrashekhar Choudhari Vishal Vashistha Ashraf Ansari Rambha Pandey Ashu Seith Bhalla Karan Madan Vijay Hadda Hariharan Iyer Deepali Jain Rakesh Kumar Saurabh Mittal Pawan Tiwari Ravindra M Pandey Ran Source Type: research
ConclusionThese data support the concept that among most tumor types at least some individual cancers may benefit from treatment with immune checkpoint inhibitors.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
CONCLUSION: Long non-coding RNA DLEU1 is likely to represent an available biomarker or a potential therapeutic target in multiple tumors.
PMID: 31969095 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Song C, Zhang J, Zhao Z, Yang Y, Meng D, Wang J, Guo C, Yuan C Tags: Curr Pharm Des Source Type: research
The development of targeted therapies has revolutionized the treatment of patients with lung cancer, especially non-small-cell lung cancer (NSCLC). Anaplastic lymphoma kinase (ALK) is a research hotspot of molecular targeted therapy for lung cancer. ALK tyrosine kinase inhibitors (TKIs) are highly effective for ALK-rearranged NSCLC-positive patients. These targeted therapies have significant clinical effects; however, they inevitably lead to acquired resistance. In previous studies, the histological transformation after ALK inhibitor treatment was mostly based on small-cell lung cancer (SCLC).
Source: Lung Cancer - Category: Cancer & Oncology Authors: Fenfang Wang, Jing Qin, Fajun Xie, Qihuan Wu, Hongyang Lu Source Type: research
Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry
Aim: To compare survival outcomes in patients with non-small cell lung cancer (NSCLC) treated with modern-era drugs (antifolates, antiangiogenics, tyrosine kinase and anaplastic lymphoma kinase inhibitors, immunotherapy) with treatment initiation in 2011-12 and 2015-16, respectively. Patients and Methods: Prospective data from Czech TULUNG Registry (960 patients from 2011-12 and 512 patients from 2015-16) were analyzed. Kaplan-Meier analysis was used to estimate overall survival (OS) and progression-free survival (PFS); Cox proportional hazards model to assess factors associated with 2-year survival. Results: Survival at 2...
Source: In Vivo - Category: Research Authors: BRATOVA, M., KARLINOVA, B., SKRICKOVA, J., PESEK, M., KOLEK, V., KOUBKOVA, L., HRNCIARIK, M., KREJCI, J., BARINOVA, M., HAVEL, L., GRYGARKOVA, I., BRAT, K. Tags: Clinical Studies Source Type: research
AbstractPersonalised medicine for primary lung cancers (PLCs) requires molecular analysis of cancer tissue or cells. The primary objective of the present prospective study was to assess the concordance between epidermal growth factor receptor (EGFR) gene mutation detection and echinoderm microtubule-associated protein-like (EML) 4-anaplastic lymphoma kinase protein (ALK) expression using liquid-based cytology (LBC) samples and matched histology samples of PLC patients. A total of 117 patients who underwent surgical resection of non-small cell PLC were enrolled. Cytological specimens scratched from the resected PLC lesion w...
Source: Virchows Archiv - Category: Pathology Source Type: research
Conclusion: These findings indicate that a majority of EBUS-TBNA specimens provide sufficient tissue for subtyping pulmonary NSCLC and SCLC while performing IHC.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Shah, U. C., Shah, A. C., Shah, C. M. Tags: Interventional pulmonology Source Type: research
Conclusion and Perspectives
The IL-6/JAK/STAT signaling cascade plays a dominant role in skeletal muscle pathophysiology. IL-6 autocrine, paracrine, and endocrine functions assign to its downstream effectors pivotal importance in skeletal muscle-wasting-associated diseases and other multiple system diseases where muscle acts in communication with other organs. Targeting the components of the JAK/STAT pathway recently emerged as a strategic approach for the treatment of inflammatory diseases and human cancer.
This review highlights the opposite outcomes on muscle biology caused by the amount of local and systemic release ...
Source: Frontiers in Physiology - Category: Physiology Source Type: research
More News: Adenocarcinoma | Bronchoscopy | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Fine Needle Aspiration | Immunotherapy | Lung Cancer | Lymphoma | Respiratory Medicine | Squamous Cell Carcinoma | Ultrasound